66 FR 193 pg. 50660 - Office of the Director, National Institutes of Health; Notice of Meeting
Type: NOTICEVolume: 66Number: 193Page: 50660
FR document: [FR Doc. 01-24837 Filed 10-3-01; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: National Institutes of Health
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Director's Council of Public Representatives.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: Director's Council of Public Representatives.
Date: October 23, 2001.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: Among the topics proposed for discussion are: (1) The science underlying complementary and alternative medicine; (2) human research protections; (3) technology transfer activities at the NIH: current issues; and (4) staff reports on NIH stem cell research activity.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, C Wing, Conf. Rm. 6, Bethesda, MD 20892.
Contact Person: Jennifer E. Gorman, NIH Public Liaison/COPR Coordinator, Office of Communications and Public Liaison, Office of the Director, National Institutes of Health, 9000 Rockville Pike, Building 1, Room 344, Bethesda, MD 20892, (301) 435-4448, gormanj@od.nih.gov.
Information is also available on the Institute's/Center's home page: www.nih.gov/about/publicliaison/index.html, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Nos.93.14, Intramural Research Training Award;93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds;93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds;93.232, Loan Repayment Program for Research Generally;93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program, National Institutes of Health, HHS)
Dated: September 26, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-24837 Filed 10-3-01; 8:45 am]
BILLING CODE 4140-01-M